GSK shares jump after landmark £1.68bn heartburn drug settlement
- Posted on October 10, 2024
- By Evening Standard
- 3 Views
GSK shares jump after landmark £1.68bn heartburn drug settlement
The pharmaceutical giant has settled the vast majority of cases around its drug Zantac in the US, boosting investor confidence in the company.
